Gut health and kidney disease: what the trials found
Updated: 4 hours ago
The short answer
Your gut and kidneys are connected, but a lower gut-toxin reading is not proof that kidney function improved. Trials of probiotics, synbiotics and fiber in chronic kidney disease have sometimes changed bacteria or toxin levels without improving filtration. A short plant-focused renal-diet study changed urine acid and toxin excretion, but did not establish slower kidney disease. The practical starting point is your meal pattern within the limits your kidney team has set, rather than a supplement sold as kidney protection.
What we cover
How gut bacteria turn undigested protein into indoxyl sulfate and p-cresyl sulfate, two toxins weakened kidneys struggle to clear. Review
The four outcomes a gut study can change: bacteria, toxin levels, the filtering number, and what happens to the person. A change in one does not establish the others.
SYNERGY: p-cresyl sulfate fell, the main indoxyl-sulfate result did not reach significance, and albuminuria rose as a secondary finding. Primary source
SYNERGY II: the 12-month feasibility trial found no between-group toxin difference, with an exploratory decline in eGFR. Primary source
Beta-glucan fiber: some free toxin measurements fell over 14 weeks, while kidney function did not significantly change. Primary source
The New Nordic Renal Diet: one week changed urine acid and toxin excretion in 18 people, an early signal rather than proof of long-term kidney protection. Primary source
How to judge a resistant-starch claim, address constipation, and make one plant-based meal upgrade without ignoring potassium or protein limits. Primary source
Timestamps
0:00 Does your gut protect your kidneys
0:37 Four outcomes a gut study can change
1:53 How kidney disease changes your gut
2:37 How gut bacteria make kidney toxins
4:31 Probiotic and synbiotic trials in kidney disease
7:18 Fiber trial: toxins fell, kidney unchanged
9:02 What a plant-focused diet changed in one week
11:49 The one meal upgrade to make this week
13:01 Constipation and kidney disease
13:51 How to judge any gut-kidney claim
References
Rossi M, Johnson DW, Morrison M, et al. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial. Clin J Am Soc Nephrol. 2016;11(2):223-231. https://doi.org/10.2215/CJN.05240515
In 37 randomized adults, p-cresyl sulfate fell, indoxyl sulfate did not significantly fall, and albuminuria rose as a secondary signal. Evidence type: randomized crossover trial.
McFarlane C, Krishnasamy R, Stanton T, et al. Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): A Feasibility Randomized Controlled Trial. Nutrients. 2021;13(12):4481. https://doi.org/10.3390/nu13124481
The 68-person feasibility trial found no toxin difference and an exploratory eGFR reduction of 3.14 mL/min/1.73 m2. Evidence type: feasibility randomized trial.
Ebrahim Z, Proost S, Tito RY, et al. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial. Nutrients. 2022;14(4):805. https://doi.org/10.3390/nu14040805 (Correction 2025;17(19):3054)
In 59 adults, some free toxin levels fell while kidney function was unchanged; the 2025 correction did not alter those results. Evidence type: randomized trial.
Hansen NM, Berg P, Rix M, et al. The New Nordic Renal Diet Induces a Pronounced Reduction of Urine Acid Excretion and Uremic Toxins in Chronic Kidney Disease Patients (Stage 3 and 4). J Ren Nutr. 2023;33(3):412-419. https://doi.org/10.1053/j.jrn.2022.09.010
In a post hoc analysis of 18 people, one week reduced urine acid and toxin excretion, without demonstrating a long-term kidney outcome. Evidence type: post hoc analysis of a crossover trial.
Headley SA, Chapman DJ, Germain MJ, et al. Effects of High Amylose-Resistant Starch on Gut Microbiota and Uremic Toxin Levels in Patients With Stage-G3a-G4 Chronic Kidney Disease: A Randomized Trial. J Ren Nutr. 2025;35(2):248-258. https://doi.org/10.1053/j.jrn.2024.09.005
In 68 adults, resistant starch lowered p-cresyl sulfate without establishing protection against kidney failure. Evidence type: randomized trial.
Sumida K, Lau WL, Kovesdy CP, et al. Microbiome modulation as a novel therapeutic approach in chronic kidney disease. Curr Opin Nephrol Hypertens. 2021;30(1):75-84. https://doi.org/10.1097/MNH.0000000000000661
Reviews possible gut-targeted approaches while emphasizing the limited evidence for preventing or treating chronic kidney disease. Evidence type: narrative review.
One study explained in plain language every week, with sources attached, plus the free kidney health guide: https://guides.selfprinciple.org/kidney
This content is for educational purposes only and is not medical advice. Always consult your healthcare provider for individual care. The views expressed are Dr. Sean Hashmi's own and do not represent his employer.
Comments